SELLAS Life Sciences Group, Inc. (SLS)

8.58 +0.46 (+5.66%) USD  |  NASDAQ  |  May 27, 16:00
8.50 -0.08 (-0.93%) After-Hours: 05:12
More

SELLAS Life Sciences Group Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Rezolute, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Whitehawk Therapeutics, Inc. Upgrade